Our Team

Micronbrane Medical
Zhubei, Taiwan

Micronbrane Medical: Making an Impact

Micronbrane Medical, a woman-led life science startup, is dedicated to enhancing human health and ensuring sustainability through innovations that reduce contamination, complexity and the cost of mNGS. Sometimes searched as Microbrane or Microbane, Micronbrane Medical is at the forefront of microbial enrichment technology.

Female card
Masters card
Global card

Dr. Mengchu Wu, our Co-Founder, CEO, and Chairwoman, co-discovered the Zwitterionic membrane for host cell depletion in metagenomic next-generation sequencing (mNGS). Building on this breakthrough, she founded Micronbrane Medical to drive innovations that reduce the time, complexity, and cost of mNGS. Today, the company offers a suite of mNGS-based products designed to optimize the entire workflow and support a growing range of research, clinical, and industrial applications.

Our Story

Our Vision

Enhancing human health and sustainability through metagenomic innovations.

scientist in a lab testing a sample

Our Leadership Team

Mengchu Wu, CEO of Micronbrane's Medical

Mengchu Wu

Co-Founder, CEO and Chairwoman

Dr. Mengchu Wu is a visionary leader with extensive experience in healthcare and biotechnology. Before co-founding Micronbrane Medical, Mengchu was CEO and CTO at Health GeneTech. Her career also encompassed engineering and application development roles at Personal Genomics and Vela Diagnostics. Prior to that, she was a Research Fellow at the National University of Singapore. Mengchu is a distinguished alumna of University of Massachusetts, Chan Medical School, earning her Ph.D. in Biomedical Sciences, and a B.S. in Biochemistry, from Fudan University.

Dr. Hau Hung, Co-Founder of Micronbrane Medical

Hau Hung

Co-Founder

Dr. Hau Hung’s diverse experience and academic achievements have equipped him with a unique perspective that drives innovation and operational precision. His previous roles include Operations Manager at Kingmax Inc., Sales Manager at Bio-REV, and Scientist at Merck. He has conducted research at prestigious institutions, including the National University of Singapore, Fred Hutchinson Cancer Research Center, and UMass Chan Medical School.

Eric Su - Chief Financial Officer of Micronbrane Medical

Eric Su

CFO

Eric brings over 30 years of financial management expertise to the company after making a significant impact in the semiconductor industry, serving as the finance director and spokesperson at KingMax, Inc. Prior to that, Eric held progressive financial roles at an automotive safety assistance system (ADAS) image sensing IC packaging company, handling finance, accounting, taxation, and strategic planning for mergers, acquisitions, and reinvestments. Eric holds an Executive Master of Business Administration from the National Tsing Hua University. His wealth of experience and strategic mindset shapes Micronbrane Medical’s financial success.

Kristi Ashton, CMO of Micronbrane Medical

Kristi Ashton

CMO

Kristi Ashton is a seasoned marketing executive with a career spanning 25 years. She holds an Executive MBA in Digital Marketing, an Interdisciplinary M.S. in Engineering, Business, and Law and a B.S in Biology. Kristi has held key leadership positions, including Head of Marketing at Gencove and Director of Digital Marketing at Guardant Health, and Associate Director of Digital Marketing at J&J, delivering substantial results and driving growth in the life science sector.

hannah

Hannah Lucio

Global Commercial Lead

Hannah Lucio has extensive expertise in business development and commercialization within the life sciences and diagnostics sectors. She has successfully driven sales growth at Oxford Nanopore Technologies, Natera, Thermo Fisher Scientific, Covaris, Versiti, Life Technologies, and Agilent Technologies. Starting her career as a microbiologist and lead scientist in state labs and at the U.S. Centers for Disease Control and Prevention, Hannah built a strong foundation in complex genomics and diagnostic products. She holds an M.A. in Strategic Planning from the University of Washington and a B.S. in Biological Science (Anatomy/Neurobiology) from Colorado State University.

Ellipse 22

Maurice Chan

RD Lead

Dr. Maurice Chan has a distinguished record of developing high-value, high-complexity NGS-based diagnostic assays. He has successfully expanded testing menus at various institutions, including obtaining MOH licenses for COVID-testing. Maurice has held key roles at MiRXES, Angsana Molecular & Diagnostics, and Changi General Hospital, where he led teams and projects that significantly contributed to the life science field. He also has a strong background in academic and government sectors, having worked at the National Cancer Centre Singapore, Vela Diagnostics, and the U.S. Centers for Disease Control and Prevention. Maurice earned his Bachelors, Masters and Doctorate in microbiology and molecular biology from the National University of Singapore and has actively published in reputed international journals.

Our Mission

Removing barriers to our understanding of microbial genomics through innovative mNGS solutions.

Our Values

Micronbrane Medical is focused on paving the way to a transformative shift in the study, diagnosis, treatment, and surveillance of infectious diseases. We are:

Company Values
tick min
Original thinkers, driven by our passion for innovation
tick min
Altruistic, we care for each other and our world
tick min
Lean, adaptable
and efficient
tick min
A diverse,
global company

Interested in joining our team?

Stay in touch! Sign up for our monthly newsletter.